GLP-1, or {glucagon-like|glucagon like|glucagon) peptide-1, is rapidly gaining a significant focus in therapeutic research, largely due to its impressive impact on treating diseases such as second type diabetes and excess body fat. Recent trials have demonstrated that beyond glucose regulation, GLP-1 medications offer benefits for circulatory funct